← Open Payments lookup

AMBER LIPPA: Open Payments

NPI 1871920439 · ATTLEBORO, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,005 in 83 payments from 14 companies in 2025. Trend: 2023 $1,186 · 2024 $1,292 · 2025 $2,005

Food & beverage: $2,005
CompanyPaymentsAmount
ABBVIE INC.19$539
QOL Medical, LLC8$306
Salix Pharmaceuticals, a division of Bausch Health US, LLC7$169
Ardelyx, Inc.15$165
Janssen Biotech, Inc.9$153
GENZYME CORPORATION4$143
Takeda Pharmaceuticals U.S.A., Inc.5$129
Madrigal Pharmaceuticals3$86
Regeneron Healthcare Solutions, Inc.3$83
Aimmune Therapeutics, Inc.3$57

Products named: Sucraid, DUPIXENT, CREON, XIFAXAN, IBSRELA, TREMFYA, ENTYVIO, RINVOQ.

Industry payments across MA — which companies pay providers there.